GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis. Maniscalco GT, Mariotto S, Hoftberger R, Capra R, et al. Neurology 2020 Jul 10. pii: WNL.0000000000010310.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Maniscalco GT, Mariotto S, Hoftberger R, Capra R, et al. GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis. Neurology 2020 Jul 10. pii: WNL.0000000000010310.
PMID: 32651290